Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (361-370 of 608) with videos related to

Pageof 61
Sort By:
Psychology and Psychotherapy|December 23, 2025
Psychological care for Huntington's disease: A qualitative study exploring interventions in the NetherlandsKasper F Van der Zwaan, Laura C M Kuijper, Pearl J C van Lonkhuizen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2000
Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancerI van Zanten-Przybysz, C F Molthoff, J C Roos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 5, 2019
Milk processing increases the allergenicity of cow's milk-Preclinical evidence supported by a human proof-of-concept provocation pilotSuzanne Abbring, Daniel Kusche, Thomas C Roos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Body composition in children and adolescents born after in vitro fertilization or spontaneous conceptionManon Ceelen, Mirjam M van Weissenbruch, Jan C Roos, et al.
Journal of Neurology|June 30, 2009
Delayed onset of the diurnal melatonin rise in patients with Huntington's diseaseN Ahmad Aziz, Hanno Pijl, Marijke Frölich, et al.
European Journal of Neurology|October 23, 2009
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's diseaseN A Aziz, H Pijl, M Frölich, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and manH J Haisma, M A Kessel, C Silva, et al.
Brain Pathology (Zurich, Switzerland)|April 15, 2006
The cerebral beta-amyloid angiopathies: hereditary and sporadicSandy X Zhang-Nunes, Marion L C Maat-Schieman, Sjoerd G van Duinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 11, 2010
Late-onset Huntington disease with intermediate CAG repeats: true or false?Justus L Groen, Rob M A de Bie, Elisabeth M J Foncke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
Pageof 61

Showing results (361-370 of 608) with videos related to

Sort By:
Pageof 61
Psychology and Psychotherapy|December 23, 2025
Psychological care for Huntington's disease: A qualitative study exploring interventions in the NetherlandsKasper F Van der Zwaan, Laura C M Kuijper, Pearl J C van Lonkhuizen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2000
Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancerI van Zanten-Przybysz, C F Molthoff, J C Roos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 5, 2019
Milk processing increases the allergenicity of cow's milk-Preclinical evidence supported by a human proof-of-concept provocation pilotSuzanne Abbring, Daniel Kusche, Thomas C Roos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2007
Body composition in children and adolescents born after in vitro fertilization or spontaneous conceptionManon Ceelen, Mirjam M van Weissenbruch, Jan C Roos, et al.
Journal of Neurology|June 30, 2009
Delayed onset of the diurnal melatonin rise in patients with Huntington's diseaseN Ahmad Aziz, Hanno Pijl, Marijke Frölich, et al.
European Journal of Neurology|October 23, 2009
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's diseaseN A Aziz, H Pijl, M Frölich, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and manH J Haisma, M A Kessel, C Silva, et al.
Brain Pathology (Zurich, Switzerland)|April 15, 2006
The cerebral beta-amyloid angiopathies: hereditary and sporadicSandy X Zhang-Nunes, Marion L C Maat-Schieman, Sjoerd G van Duinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 11, 2010
Late-onset Huntington disease with intermediate CAG repeats: true or false?Justus L Groen, Rob M A de Bie, Elisabeth M J Foncke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
Pageof 61